These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 310464)

  • 1. Mode of action of levamisole.
    Goldstein G
    J Rheumatol Suppl; 1978; 4():143-8. PubMed ID: 310464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targets and mechanisms of levamisole-induced immunostimulation (author's transl)].
    Renoux G; Renoux M
    Nouv Presse Med; 1978 Jan; 7(3):197-201. PubMed ID: 307228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of levamisole on autologous rosette-forming cells in nude mice.
    Van Wauwe J; Van Nijen G
    Clin Exp Immunol; 1977 Dec; 30(3):465-8. PubMed ID: 304789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hypothesis. The mechanism of action of levamisole: immune restoration through enhanced cell maturation.
    Amery WK
    J Reticuloendothel Soc; 1978 Aug; 24(2):187-93. PubMed ID: 309007
    [No Abstract]   [Full Text] [Related]  

  • 5. The general immunopharmacology of levamisole.
    Renoux G
    Drugs; 1980 Aug; 20(2):89-99. PubMed ID: 6995097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levamisole, a chemically defined substance with immunostimulating potential--a review].
    Staber GF
    Fortschr Med; 1976 May; 94(14):793-800. PubMed ID: 5347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levamisole -- a drug modifying immunologic phenomena].
    Bogdanikowa B
    Postepy Hig Med Dosw; 1979; 33(2):125-46. PubMed ID: 384382
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanisms of action of levamisole, stimulating cellular immune responses].
    Renoux G; Renoux M
    Ann Immunol (Paris); 1977; 128(1-2):275-7. PubMed ID: 322583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of the administration of levamisole on the reactivity of T-lymphocytes in advanced cancer patients].
    Renoux G; Renoux M
    Nouv Presse Med; 1976 Jan; 5(2):67-70. PubMed ID: 772602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of T-cell mediated immunity by levamisole.
    Renoux G; Renoux M; Teller MN; McMahon S; Guillaumin JM
    Clin Exp Immunol; 1976 Aug; 25(2):288-96. PubMed ID: 782749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levamisole - a new immunostimulant].
    Rachkov SM
    Ter Arkh; 1976; 48(11):133-8. PubMed ID: 1088219
    [No Abstract]   [Full Text] [Related]  

  • 13. Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered.
    Faanes RB; Dillon P; Choi YS
    Clin Exp Immunol; 1977 Mar; 27(3):502-6. PubMed ID: 405166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levamisole and cellular immunity in rheumatoid arthritis--a review.
    Mowat AG
    J Rheumatol Suppl; 1978; 4():55-61. PubMed ID: 366144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Various aspects of the mechanism of action of levamisole].
    Chumakova MM
    Ter Arkh; 1978; 50(9):146-53. PubMed ID: 360467
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of the reticulo-epithelial (RE) cell network in the immuno-neuroendocrine regulation of intrathymic lymphopoiesis.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(3A):1871-88. PubMed ID: 10928121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulators--thymus factor X (TFX) and levamisole in immune reactions and inflammatory processes.
    Giełdanowski J
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):121-32. PubMed ID: 7305628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of levamisole on the activity of the blood T-lymphocytes and of factors they produce in patients with laryngeal cancer].
    Volosevich LI; Lukach EV; Krivokhatskaia LD
    Eksp Onkol; 1988; 10(3):54-7. PubMed ID: 2970382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modes of action of levamisole].
    Renoux G
    Nouv Presse Med; 1977 Nov; 6(38):3552. PubMed ID: 304562
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of levamisole on cell-mediated immunity and suppressor cell function.
    Sampson D; Lui A
    Cancer Res; 1976 Mar; 36(3):952-5. PubMed ID: 1253182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.